SCHEMBL30797700

SCHEMBL30797700

CC(C)(C)OC(=O)NCCCCOCCOc1cc(-c2cnns2)cc2c1cnn2C1CCCCO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 6/20 0.47
▸ SCN9A Q15858 1/20 0.37
▸ ATRIP Q8WXE1 3/20 0.36
▸ FPR3 P25089 2/20 0.33
▸ FPR2 P25090 2/20 0.33
▸ DDB1 Q16531 2/20 0.33
▸ CRBN Q96SW2 2/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33
▸ RXRG P48443 1/20 0.33
▸ CYP1A1 P04798 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2B6 P20813 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ CYP3A43 Q9HB55 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ CNR1 P21554 1/20 0.31
▸ TRIM24 O15164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27378404 0.86 ATR (0.46) ATRSCN9AATRIPDDB1CRBN
SCHEMBL30797746 0.86 ATR (0.46) ATRSCN9AATRIPDDB1CRBN
SCHEMBL30797724 0.86 ATR (0.43) ATRATRIPFPR3FPR2DDB1
SCHEMBL30797903 0.86 ATR (0.50) ATRSCN9AATRIPDDB1CRBN
SCHEMBL30797980 0.85 ATR (0.49) ATRSCN9AATRIPFPR3FPR2
SCHEMBL30797968 0.85 ATR (0.51) ATRSCN9AATRIPFPR3FPR2
SCHEMBL27376610 0.85 ATR (0.51) ATRSCN9AATRIPFPR3FPR2
SCHEMBL30797874 0.84 ATR (0.48) ATRSCN9AATRIPFPR3FPR2
SCHEMBL30797812 0.84 ATR (0.46) ATRSCN9AATRIPFPR3FPR2
SCHEMBL30797758 0.84 ATR (0.46) ATRSCN9AATRIPFPR3FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584266-A1 NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF Cambridge Enterprise Limited (GB) 2025-07-16 — — EP disclosed
WO-2024052701-A1 NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-03-14 — — WO disclosed
Send feedback